Market Overview

UPDATE: RBC Capital Markets Downgrades LHC Group Ahead of Medicare Home Health Rebasing

Related LHCG
UPDATE: Credit Suisse Upgrades LHC Group to Outperform, Sees 2015 As An Inflection
Benzinga's Top Upgrades

In a report published Monday, RBC Capital Markets analyst Frank G. Morgan downgraded the rating on LHC Group (NASDAQ: LHCG) from Sector Perform to Underperform, and lowered the price target from $20.00 to $17.00.

In the report, RBC Capital Markets noted, “We do not believe the market is adequately pricing in Home Health earnings downside from the forthcoming rebasing, and we are lowering our outlook for the segment. Note that Home Health stocks are up an average 11.5% since immediately prior to the proposed rule release, including LHCG up 0.8%.”

LHC Group closed on Friday at $22.71.

Latest Ratings for LHCG

DateFirmActionFromTo
Dec 2014Credit SuisseUpgradesUnderperformOutperform
Nov 2014BairdUpgradesUnderperformNeutral
Aug 2014Credit SuisseMaintainsUnderperform

View More Analyst Ratings for LHCG
View the Latest Analyst Ratings

Posted-In: Frank G. Morgan RBC Capital MarketsAnalyst Color Downgrades Analyst Ratings

 

Related Articles (LHCG)

Around the Web, We're Loving...

Get Benzinga's Newsletters